These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8105853)

  • 1. Imaging and dosimetry determinations using radiolabeled antibodies.
    Carrasquillo J
    Cancer Treat Res; 1993; 68():65-97. PubMed ID: 8105853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody.
    Carrasquillo JA; Bunn PA; Keenan AM; Reynolds JC; Schroff RW; Foon KA; Su MH; Gazdar AF; Mulshine JL; Oldham RK
    N Engl J Med; 1986 Sep; 315(11):673-80. PubMed ID: 3489185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation.
    Bertram JH; Gill PS; Levine AM; Boquiren D; Hoffman FM; Meyer P; Mitchell MS
    Blood; 1986 Sep; 68(3):752-61. PubMed ID: 3488778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma.
    Carrasquillo JA; Mulshine JL; Bunn PA; Reynolds JC; Foon KA; Schroff RW; Perentesis P; Steis RG; Keenan AM; Horowitz M
    J Nucl Med; 1987 Mar; 28(3):281-7. PubMed ID: 3102699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
    Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
    Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
    Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
    Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
    Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
    Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.
    Press OW; Eary JF; Badger CC; Martin PJ; Appelbaum FR; Levy R; Miller R; Brown S; Nelp WB; Krohn KA
    J Clin Oncol; 1989 Aug; 7(8):1027-38. PubMed ID: 2666588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
    Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
    Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
    Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14.
    Sharkey RM; Goldenberg DM; Murthy S; Pinsky H; Vagg R; Pawlyk D; Siegel JA; Wong GY; Gascon P; Izon DO
    Cancer; 1993 Mar; 71(6):2082-96. PubMed ID: 8443758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3.
    da Costa L; Carde P; Lumbroso JD; Ricard M; Pfreundschuh M; Bosq J; Manil L; Diehl V; Parmentier C
    Ann Oncol; 1992 Sep; 3 Suppl 4():53-7. PubMed ID: 1333272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
    Press OW; Eary JF; Appelbaum FR; Martin PJ; Badger CC; Nelp WB; Glenn S; Butchko G; Fisher D; Porter B
    N Engl J Med; 1993 Oct; 329(17):1219-24. PubMed ID: 7692295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
    Sharkey RM; Behr TM; Mattes MJ; Stein R; Griffiths GL; Shih LB; Hansen HJ; Blumenthal RD; Dunn RM; Juweid ME; Goldenberg DM
    Cancer Immunol Immunother; 1997 May; 44(3):179-88. PubMed ID: 9191878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.
    Rosen ST; Zimmer AM; Goldman-Leikin R; Gordon LI; Kazikiewicz JM; Kaplan EH; Variakojis D; Marder RJ; Dykewicz MS; Piergies A
    J Clin Oncol; 1987 Apr; 5(4):562-73. PubMed ID: 3549989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma.
    Mulshine JL; Carrasquillo JA; Weinstein JN; Keenan AM; Reynolds JC; Herdt J; Bunn PA; Sausville E; Eddy J; Cotelingam JD
    Cancer Res; 1991 Jan; 51(2):688-95. PubMed ID: 1985786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.
    Illidge T; Honeychurch J; Vandersteen A; Cragg M
    Cancer Biother Radiopharm; 2000 Dec; 15(6):581-91. PubMed ID: 11190490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
    Juweid ME; Stadtmauer E; Hajjar G; Sharkey RM; Suleiman S; Luger S; Swayne LC; Alavi A; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3292s-3303s. PubMed ID: 10541378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
    Foss FM; Raubitscheck A; Mulshine JL; Fleisher TA; Reynolds JC; Paik CH; Neumann RD; Boland C; Perentesis P; Brown MR; Frincke JM; Lollo CP; Larson SM; Carrasquillo JA
    Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.